Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-16 10:46 am Sale |
2020-12-31 | 13G | Arbutus Biopharma Corporation ABUS |
Foresite Capital Fund IV, L.P. | 0 0.000% |
-3,705,128 (Position Closed) |
Filing History |
| 2021-02-12 3:26 pm Purchase |
2021-02-05 | 13G | Pharvaris N.V. PHVS |
Foresite Capital Fund IV, L.P. | 3,926,068 12.300% |
3,926,068 (New Position) |
Filing History |
| 2020-12-14 9:24 pm Purchase |
2020-12-03 | 13D | Kinnate Biopharma Inc. KNTE |
Foresite Capital Fund IV, L.P. | 10,838,311 25.000% |
10,838,311 (New Position) |
Filing History |
| 2020-08-03 3:28 pm Purchase |
2020-07-24 | 13G | Nurix Therapeutics, Inc. NRIX |
Foresite Capital Fund IV, L.P. | 3,160,784 8.500% |
3,160,784 (New Position) |
Filing History |